newsfilter
← Latest News
Business Wire·

NeoGenomics to Report First Quarter 2026 Financial Results on April 28, 2026

NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced that it will report its first quarter 2026 financial results after the close of the